Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Waldenstrom Macroglobulinemia 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, T-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1

Interventions

fludarabine phosphate 8Cyclophosphamide 7Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6Whole-Body Irradiation 5Cyclosporine 5Tacrolimus 4Methotrexate 4Alemtuzumab 4Rituximab 3thymoglobulin 2fludarabine 2Transplantation 2Radiotherapy 2Melphalan 2Epoetin Alfa 2Cyclosporins 2Busulfan 2Antilymphocyte Serum 2tipifarnib 1ruxolitinib 1nelarabine 1merphos 1blinatumomab 1aldesleukin 1Thiotepa 1Therapeutics 1Thalidomide 1Sunitinib 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Large Granular Lymphocytic × nelarabine × Clear all
NCT00003635 2013-07-18

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡